Rare lephants
Screener

Atossa Therapeutics, Inc.

ATOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13G Feb 4, 2022
SC 13G/A Jan 13, 2022 ATOSSA THERAPEUTICS, INC.
10-Q Nov 15, 2021 FORM 10-Q
8-K Nov 15, 2021 FORM 8-K
8-K Oct 6, 2021 FORM 8-K
DEFA14A Sep 14, 2021 FORM DEFA14A
8-K Sep 8, 2021 FORM 8-K
10-Q Aug 13, 2021 FORM 10-Q
8-K Aug 13, 2021 FORM 8-K
DEF 14A Aug 9, 2021 FORM DEF 14A
PRE 14A Jul 29, 2021 FORM PRE 14A
4 Jul 7, 2021 FORM 4
8-K May 18, 2021 FORM 8-K
4 May 18, 2021 FORM 4
4 May 18, 2021 FORM 4
4 May 18, 2021 FORM 4
4 May 18, 2021 FORM 4
4 May 18, 2021 FORM 4
4 May 18, 2021 FORM 4
4 May 18, 2021 FORM 4
4 May 18, 2021 FORM 4
10-Q May 14, 2021 FORM 10-Q
8-K May 14, 2021 FORM 8-K
DEFA14A May 11, 2021 FORM DEFA14A
EFFECT Apr 29, 2021
← Newer Page 8 of 26 · 641 filings Older →